NEW YORK (GenomeWeb News) – Transasia Bio-Medicals today announced a deal to distribute in India molecular diagnostics products made by Gen-Probe.
In an e-mail to GenomeWeb Daily News, a Gen-Probe spokesman said the agreement is for certain products including the company's Aptima assays, as well as the Panther platform, launched late last year in Europe. He declined to disclose financial and other terms of the deal.
In May, San Diego-based Gen-Probe filed with the US Food and Drug Administration for 510(k) clearance of the fully automated and integrated molecular testing system, which complements Gen-Probe's Tigris system.
Based in Mumbai, India, Transasia sells and distributes clinical diagnostic products.